Amedeo Smart

Free Medical Literature Service




  Free Subscription


2 Am J Respir Crit Care Med
4 Ann Intern Med
1 Clin Chem
9 Clin Infect Dis
2 Emerg Infect Dis
1 Graefes Arch Clin Exp Ophthalmol
1 Infect Control Hosp Epidemiol
4 Int J Infect Dis
2 Intensive Care Med
9 J Infect
14 J Med Virol
4 J Virol
1 Lancet
2 Lancet Infect Dis
2 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
2 Nature
1 Radiologia (Engl Ed)
1 Travel Med Infect Dis
2 Zhonghua Jie He He Hu Xi Za Zhi

    Am J Respir Crit Care Med

  1. KERCHBERGER VE, Bastarache JA
    Pulmonary Vasculopathy in COVID-19 ARDS: A Step Closer to the Full Picture.
    Am J Respir Crit Care Med. 2022 Jun 8. doi: 10.1164/rccm.202205-1019.
    >> Share

  2. VILLALBA JA, Hilburn CF, Garlin MA, Elliott GA, et al
    Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and ARDS.
    Am J Respir Crit Care Med. 2022 Jun 7. doi: 10.1164/rccm.202109-2150.
    >> Share

    Ann Intern Med

  3. KING D
    Patients surviving COVID-19 had increased risk for adverse mental health outcomes vs. persons without COVID-19.
    Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0031.
    >> Share

  4. SHAH A, O'Horo JC
    In patients with COVID-19 receiving IMV or ECMO, adding baricitinib to usual care reduced all-cause mortality.
    Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0033.
    >> Share

  5. VASSILOPOULOS A, Mylonakis E
    In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death.
    Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0038.
    >> Share

  6. JOHNSON MG, Puenpatom A, Moncada PA, Burgess L, et al
    Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
    Ann Intern Med. 2022 Jun 7. doi: 10.7326/M22-0729.
    >> Share


  7. PANDEY BD, Morita K, Costello A
    Twin crises in Nepal: covid-19 and climate change.
    BMJ. 2022;377:o1434.
    >> Share

    Three more points about Paxlovid for covid-19.
    BMJ. 2022;377:o1397.
    >> Share

  9. DYER O
    Covid-19: Doctor who sold hydroxychloroquine as "magic bullet" treatment is jailed.
    BMJ. 2022;377:o1395.
    >> Share

  10. WISE J
    Private cancer provider collapses despite drive to tackle NHS backlog.
    BMJ. 2022;377:o1401.
    >> Share

    Clin Chem

  11. AOKI A, Mori Y, Okamoto Y, Jinno H, et al
    PCR-Based Screening Tests for SARS-CoV-2 Mutations: What Is the Best Way to Identify Variants?
    Clin Chem. 2022 Jun 7. pii: 6603702. doi: 10.1093.
    >> Share

    Clin Infect Dis

  12. LIN Y, Yue S, Yang Y, Yang S, et al
    Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern (VOCs): A Small-scale Clinical Trial.
    Clin Infect Dis. 2022 Jun 6. pii: 6603292. doi: 10.1093.
    >> Share

  13. RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
    Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among Health Care Workers with a Vaccine Mandate.
    Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
    >> Share

  14. STRAUS W, Urdaneta V, Esposito DB, Mansi JA, et al
    Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide.
    Clin Infect Dis. 2022 Jun 6. pii: 6603291. doi: 10.1093.
    >> Share

  15. ALHABBAB RY, Algaissi A, Mahmoud AB, Alkayyal AA, et al
    MERS-CoV infection elicits long-lasting specific antibody, T and B cell immune responses in recovered individuals.
    Clin Infect Dis. 2022 Jun 8. pii: 6604398. doi: 10.1093.
    >> Share

  16. DOYLE TJ, Kiros GE, Schmitt-Matzen EN, Propper R, et al
    Maternal and perinatal outcomes associated with SARS-CoV-2 infection during pregnancy, Florida, 2020-2021: A retrospective cohort study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604396. doi: 10.1093.
    >> Share

  17. WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
    mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
    >> Share

  18. BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
    SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021.
    Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
    >> Share

  19. LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
    Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
    >> Share

  20. LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
    Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine.
    Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
    >> Share

    Emerg Infect Dis

  21. SILA T, Sunghan J, Laochareonsuk W, Surasombatpattana S, et al
    Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July-September 2021.
    Emerg Infect Dis. 2022;28.
    >> Share

  22. DAOUK SK, Kamau E, Adachi K, Aldrovandi GM, et al
    Zoster Meningitis in an Immunocompetent Child after COVID-19 Vaccination, California, USA.
    Emerg Infect Dis. 2022;28.
    >> Share

    Graefes Arch Clin Exp Ophthalmol

  23. MIRGHORBANI M, Bazvand F, Riazi-Esfahani H, Bahar MM, et al
    Post-intravitreal injection endophthalmitis pattern during the COVID-19 pandemic with implementation of patients' masking.
    Graefes Arch Clin Exp Ophthalmol. 2022 Jun 9. pii: 10.1007/s00417-022-05726.
    >> Share

    Infect Control Hosp Epidemiol

  24. LI DF, Alhmidi H, Scott JG, Charnas IC, et al
    A simulation study to evaluate contamination during reuse of N95 respirators and effectiveness of interventions to reduce contamination.
    Infect Control Hosp Epidemiol. 2022;43:764-769.
    >> Share

    Int J Infect Dis

  25. BORDI L, Sberna G, Piscioneri CN, Cocchiara RA, et al
    Longitudinal dynamics of SARS-CoV2 anti-Receptor Binding Domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccination.
    Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00325.
    >> Share

  26. LAI X, Deng S, Hu L, Chen R, et al
    J-shaped associations and joint effects of fasting glucose with inflammation and cytokines on COVID-19 mortality.
    Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00324.
    >> Share

  27. HERNANDEZ PORTO M, Garcia S, Delgado T, Rodriguez Y, et al
    Humoral response to SARS-COV-2 after vaccination and C in dialyzed patients.
    Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00335.
    >> Share

  28. KHONGYOT T, Moriyasu T
    Invasive Pneumococcal Disease diminish during the coronavirus disease 2019 in Japan between 2019 and 2022.
    Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00333.
    >> Share

    Intensive Care Med

  29. LABRO G, Tubach F, Belin L, Dubost JL, et al
    Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial.
    Intensive Care Med. 2022 Jun 9. pii: 10.1007/s00134-022-06721.
    >> Share

  30. MEYNAAR IA, van Rijn S, Ottens TH, van Burgel ND, et al
    Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists.
    Intensive Care Med. 2022 Jun 7. pii: 10.1007/s00134-022-06750.
    >> Share

    J Infect

  31. LV P, Hu B, Hua R, Zhang J, et al
    A novelly designed protein antagonist confers potent neutralization against SARS-COV-2 variants of concern.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00350.
    >> Share

  32. IJAZ S, Dicks S, Jegatheesan K, Parker E, et al
    Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00339.
    >> Share

  33. ABDI B, Ndoadoumgue AL, Djebara S, Zafilaza K, et al
    High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00346.
    >> Share

  34. WANG B, Fu J, Lu A, Yang J, et al
    Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.
    J Infect. 2022 May 31. pii: S0163-4453(22)00337.
    >> Share

  35. MELLON G, Rouquette A, Fac C, Carton B, et al
    SARS-CoV-2 seroprevalence in the adult detainees of the Paris area in 2021: A multicenter cross-sectional study.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00345.
    >> Share

  36. LI Y, Guo Y, Duan Y
    Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00348.
    >> Share

  37. STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00340.
    >> Share

  38. GUO Z, Zhao S, Ryu S, Mok CKP, et al
    Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00344.
    >> Share

  39. ZHANG Y, Li J, Jiang L, Chen Q, et al
    Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00342.
    >> Share

    J Med Virol

  40. GIRAY BG, Acik GG
    SARS-CoV-2and Mutation RT-qPCR Test Positivity Correlation with ABO and Rh Blood Types.
    J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27923.
    >> Share

  41. CHEN YQ, Ji YF, Chen JM
    Dual impacts of the COVID-19 non-pharmaceutical interventions on other infectious diseases.
    J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27922.
    >> Share

  42. LI H, Chen Z, Liu X, Hu P, et al
    T cell epitopes are largely conserved in the SARS-CoV-2 Omicron subvariant (BA.1, BA.2, BA.3 and GKA).
    J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27925.
    >> Share

  43. CHEUNG CL, Ho SC, Krishnamoorthy S, Li GH, et al
    COVID-19 and Platelet Traits: A Bi-directional Mendelian Randomization Study.
    J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27920.
    >> Share

  44. MERCIER J, Osman M, Bouiller K, Tipirdamaz C, et al
    Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: the ANOSVID study.
    J Med Virol. 2022 Jun 7. doi: 10.1002/jmv.27918.
    >> Share

  45. IDIZ UO, Yurttas TT, Degirmencioglu S, Orhan B, et al
    Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients.
    J Med Virol. 2022 Jun 6. doi: 10.1002/jmv.27917.
    >> Share

  46. TSAGKARIS C, Eleftheriades A, Laubscher L, Vladyckuk V, et al
    Viruses monkeying around with surgical safety: Monkeypox preparedness in surgical settings.
    J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27915.
    >> Share

  47. BREHM TT, Pfefferle S, von Possel R, Karolyi M, et al
    Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for SARS-CoV-2 delta and omicron variants.
    J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27916.
    >> Share

  48. AU TY, Assavarittirong C
    The potential rationale of COVID-19 vaccine-induced myopericarditis.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27910.
    >> Share

  49. SAIED AA, Nascimento MSL, Rangel AHDN, Skowron K, et al
    Transchromosomic bovines (TcB)-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1 and Influenza A virus.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27907.
    >> Share

  50. ZHAO L, Li Y, Yi W, Yan K, et al
    The clinical and bioinformatics analysis for the role of anti-hypertension drugs on mortality among patients with hypertension hospitalized with COVID-19.
    J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27914.
    >> Share

  51. MAK GCK, Lau SSY, Wong KKY, Lau CS, et al
    Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS-CoV-2 Omicron variant BA.2 sublineage.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27908.
    >> Share

  52. NAH EH, Cho S, Park H, Kim S, et al
    Antibody response after two doses of homologous or heterologous SARS-CoV-2 vaccines in healthcare workers at health promotion centers: a prospective observational study.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27911.
    >> Share

  53. OKTAY GULTEKIN E, Gultekin O, Coskun A, Aksak T, et al
    Antibody response three months after SARS-CoV-2 infection.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27909.
    >> Share

    J Virol

  54. LAVIE M, Dubuisson J, Belouzard S
    SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
    >> Share

  55. SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
    A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
    J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
    >> Share

  56. ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
    Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".
    J Virol. 2022 Jun 6:e0074522. doi: 10.1128/jvi.00745.
    >> Share

  57. CHEN X, Li J, Yang L, Zhou Y, et al
    Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
    J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
    >> Share


    Warning Against Counterfeit At-home COVID-19 Tests.
    JAMA. 2022;327:2067.
    >> Share

  59. RUBIN R
    From Positive to Negative to Positive Again-The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid.
    JAMA. 2022 Jun 8. pii: 2793357. doi: 10.1001/jama.2022.9925.
    >> Share

  60. DOWELL D, Lindsley WG, Brooks JT
    Reducing SARS-CoV-2 in Shared Indoor Air.
    JAMA. 2022 Jun 7. pii: 2793289. doi: 10.1001/jama.2022.9970.
    >> Share

  61. LI Y
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
    JAMA. 2022;327:2147-2148.
    >> Share

  62. LATRONICO N, Rasulo FA, Piva S
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022;327:2149.
    >> Share

  63. BAI W, Jackson T, Xiang YT
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022;327:2148-2149.
    >> Share

  64. SEVIN CM, Ely EW
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022;327:2149-2150.
    >> Share

  65. MASLO C, Toubkin M
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave-Reply.
    JAMA. 2022;327:2148.
    >> Share

  66. HEESAKKERS H, van den Boogaard M, Zegers M
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19-Reply.
    JAMA. 2022;327:2150-2151.
    >> Share


  67. CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
    Transforming or tinkering: the world remains unprepared for the next pandemic threat.
    Lancet. 2022;399:1995-1999.
    >> Share

    Lancet Infect Dis

  68. USHER AD
    FIND documents dramatic reduction in COVID-19 testing.
    Lancet Infect Dis. 2022 Jun 2. pii: S1473-3099(22)00376.
    >> Share

  69. MONGE S, Rojas-Benedicto A, Olmedo C, Mazagatos C, et al
    Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study.
    Lancet Infect Dis. 2022 Jun 2. pii: S1473-3099(22)00292.
    >> Share

    MMWR Morb Mortal Wkly Rep

  70. KRISS JL, Hung MC, Srivastav A, Black CL, et al
    COVID-19 Vaccination Coverage, by Race and Ethnicity - National Immunization Survey Adult COVID Module, United States, December 2020-November 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:757-763.
    >> Share

  71. PAMPATI S, Rasberry CN, McConnell L, Timpe Z, et al
    Ventilation Improvement Strategies Among K-12 Public Schools - The National School COVID-19 Prevention Study, United States, February 14-March 27, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:770-775.
    >> Share

    N Engl J Med

    Protection Due to Previous SARS-CoV-2 Infection.
    N Engl J Med. 2022;386.
    >> Share

  73. SCHERER EM, Babiker A, Adelman MW, Allman B, et al
    SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.
    N Engl J Med. 2022 Jun 8. doi: 10.1056/NEJMc2202861.
    >> Share

  74. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting the Immunocompromised from Covid-19.
    N Engl J Med. 2022;386:e71.
    >> Share

    Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19.
    N Engl J Med. 2022;386:2236-2238.
    >> Share


  76. Metal waste and dodging long COVID.
    Nature. 2022;606:233.
    >> Share

  77. Flying salamanders, falling lifespans - the week in infographics.
    Nature. 2022 Jun 7. pii: 10.1038/d41586-022-01590.
    >> Share

    Radiologia (Engl Ed)

  78. CALVILLO-BATLLES P, Cerda-Alberich L, Fonfria-Esparcia C, Carreres-Ortega A, et al
    Development of severity and mortality prediction models for covid-19 patients at emergency department including the chest x-ray.
    Radiologia (Engl Ed). 2022;64:214-227.
    >> Share

    Travel Med Infect Dis

  79. ALARCON-BRAGA EA, Hernandez-Bustamante EA, Salazar-Valdivia FE, Valdez-Cornejo VA, et al
    Acceptance towards Covid-19 vaccination in Latin America and the Caribbean: A systematic review and meta-analysis.
    Travel Med Infect Dis. 2022 Jun 6:102369. doi: 10.1016/j.tmaid.2022.102369.
    >> Share

    Zhonghua Jie He He Hu Xi Za Zhi

  80. LIU J, Wu JL, Liu GC, Jiang P, et al
    [Research progress on physiological changes caused by wearing N95 mask in patients with chronic obstruction pulmonary disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:598-602.
    >> Share

  81. XU FY, Zhai ZG
    [Annual review of venous thromboembolism in 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:588-592.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016